Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
249.51
Dollar change
+12.84
Percentage change
5.43
%
Index- P/E107.66 EPS (ttm)2.32 Insider Own3.88% Shs Outstand38.68M Perf Week7.89%
Market Cap9.66B Forward P/E64.80 EPS next Y3.85 Insider Trans-1.53% Shs Float37.20M Perf Month-1.91%
Income90.95M PEG- EPS next Q0.38 Inst Own89.34% Short Float5.87% Perf Quarter12.35%
Sales1.06B P/S9.12 EPS this Y35.29% Inst Trans1.14% Short Ratio6.62 Perf Half Y-5.67%
Book/sh30.48 P/B8.19 EPS next Y36.18% ROA6.21% Short Interest2.18M Perf Year-4.37%
Cash/sh7.47 P/C33.39 EPS next 5Y- ROE8.35% 52W Range180.93 - 348.67 Perf YTD-0.81%
Dividend Est.- P/FCF117.58 EPS past 5Y66.20% ROI6.50% 52W High-28.44% Beta0.52
Dividend TTM- Quick Ratio3.49 Sales past 5Y19.41% Gross Margin63.55% 52W Low37.90% ATR (14)9.76
Dividend Ex-Date- Current Ratio6.06 EPS Y/Y TTM4515.14% Oper. Margin8.67% RSI (14)49.29 Volatility4.37% 3.41%
Employees4200 Debt/Eq0.20 Sales Y/Y TTM24.95% Profit Margin8.59% Recom1.60 Target Price280.00
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q1284.05% Payout0.00% Rel Volume1.17 Prev Close236.67
Sales Surprise-0.68% EPS Surprise8.76% Sales Q/Q28.69% EarningsFeb 22 AMC Avg Volume329.89K Price249.51
SMA20-2.47% SMA50-1.40% SMA200-4.72% Trades Volume389,894 Change5.43%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Downgrade JP Morgan Overweight → Neutral $284 → $250
Sep-06-23Initiated Morgan Stanley Equal-Weight $265
Jul-19-23Initiated Robert W. Baird Outperform $375
Mar-29-23Downgrade Needham Buy → Hold
Jan-30-23Initiated Piper Sandler Overweight $275
Nov-04-22Upgrade Citigroup Neutral → Buy $217 → $212
Oct-12-22Initiated Jefferies Buy $230
Oct-05-22Downgrade Citigroup Buy → Neutral $170 → $217
Sep-09-22Upgrade Needham Hold → Buy
Jul-18-22Initiated RBC Capital Mkts Outperform $195
Feb-27-24 09:45AM
Feb-26-24 11:42AM
Feb-23-24 11:40AM
10:44AM
12:11AM
05:40PM Loading…
Feb-22-24 05:40PM
04:35PM
04:35PM
04:05PM
Feb-20-24 07:12AM
Feb-18-24 01:26PM
Feb-15-24 10:00AM
Feb-01-24 04:05PM
Jan-18-24 11:39AM
Dec-22-23 09:37AM
07:01AM Loading…
Dec-21-23 07:01AM
Dec-19-23 10:30AM
Dec-18-23 07:50PM
Nov-30-23 09:55AM
07:37AM
Nov-28-23 09:54AM
09:00AM
Nov-17-23 01:03PM
Nov-14-23 04:05PM
10:19AM
Nov-10-23 05:43PM
Nov-03-23 08:59AM
08:29AM
08:18AM
Nov-02-23 06:09PM
05:20PM Loading…
05:20PM
04:05PM
Nov-01-23 04:05PM
Oct-27-23 04:44AM
Oct-24-23 11:42AM
Oct-12-23 11:03AM
Oct-11-23 11:38AM
Oct-05-23 04:05PM
Oct-04-23 11:02PM
09:50AM
Sep-27-23 09:55AM
Sep-22-23 08:09AM
05:20AM
Sep-21-23 09:40AM
Sep-20-23 01:45PM
Sep-19-23 06:20AM
Sep-14-23 07:38PM
01:09PM
Sep-11-23 07:55AM
Sep-06-23 11:42AM
09:36AM
Sep-05-23 09:40AM
Sep-01-23 09:55AM
Aug-31-23 11:31AM
Aug-30-23 08:15AM
Aug-23-23 04:05PM
05:58AM
Aug-22-23 10:28AM
Aug-18-23 12:41PM
12:35PM
Aug-17-23 11:21AM
11:12AM
09:09AM
09:00AM
Aug-16-23 10:21AM
Aug-14-23 01:22PM
11:31AM
Aug-11-23 10:34AM
Aug-10-23 11:48AM
11:37AM
Aug-09-23 10:31AM
Aug-08-23 12:48PM
11:21AM
Aug-07-23 12:12PM
Aug-04-23 12:30PM
12:08PM
10:07AM
07:22AM
Aug-02-23 02:20PM
11:51AM
07:26AM
Aug-01-23 05:25PM
04:19PM
04:05PM
Jul-26-23 04:05PM
Jul-25-23 04:46AM
Jul-12-23 07:43AM
Jul-11-23 06:05PM
Jul-08-23 10:21AM
Jul-05-23 04:05PM
Jun-27-23 04:41AM
Jun-26-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:51AM
Jun-08-23 08:41AM
Jun-07-23 08:30AM
07:47AM
Jun-01-23 10:23AM
09:00AM
May-31-23 08:53PM
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grewal HarpreetDirectorJan 03Sale240.8217040,9398,980Jan 04 07:34 PM
Sarna SurbhiDirectorJan 02Sale247.688521,0532,295Jan 04 07:36 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryDec 27Option Exercise22.042,45053,99863,597Dec 29 07:31 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryDec 01Sale226.42600135,85162,251Dec 05 07:55 PM
O'Rourke BridgetDirectorNov 30Sale226.4115033,9624,214Dec 04 07:41 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryNov 14Sale214.14600128,48263,037Nov 16 07:35 PM
Elsesser AdamCEO and PresidentOct 11Option Exercise7.759,67074,9429,670Oct 13 07:33 PM
Elsesser AdamCEO and PresidentOct 11Sale215.769,6702,086,4170Oct 13 07:33 PM
Shiu LambertChief Accounting OfficerOct 09Option Exercise12.362,75033,99019,466Oct 11 07:31 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryOct 02Sale237.82600142,69163,637Oct 04 07:30 PM
Grewal HarpreetDirectorOct 02Sale240.9917040,9689,150Oct 04 07:44 PM
Sarna SurbhiDirectorOct 02Sale240.998520,4842,380Oct 04 07:34 PM
Elsesser AdamCEO and PresidentSep 11Option Exercise7.759,66674,9129,666Sep 13 07:48 PM
Elsesser AdamCEO and PresidentSep 11Sale298.769,6662,887,8210Sep 13 07:48 PM
Kassing Don W.DirectorSep 08Sale288.66444128,1651,458Sep 12 08:03 PM
Roberts JohannaEVP, Gen. Counsel & SecretarySep 01Sale265.11600159,06764,237Sep 06 08:03 PM
Grewal HarpreetDirectorSep 01Sale266.6234090,6519,320Sep 06 08:02 PM
O'Rourke BridgetDirectorSep 01Sale266.6210026,6624,364Sep 06 07:59 PM
Sarna SurbhiDirectorSep 01Sale266.628522,6632,465Sep 06 08:01 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryAug 14Sale249.85600149,91064,837Aug 16 08:07 PM
Elsesser AdamCEO and PresidentAug 11Option Exercise7.759,66674,9129,666Aug 14 08:57 PM
Elsesser AdamCEO and PresidentAug 11Sale247.219,6662,389,5730Aug 14 08:57 PM
Kassing Don W.DirectorAug 08Sale251.0032381,0731,902Aug 09 08:09 PM
Wilder ThomasDirectorAug 07Sale253.4834086,183340Aug 09 08:11 PM
Elsesser AdamCEO and PresidentJul 11Option Exercise7.759,66674,9129,666Jul 13 09:08 PM
Elsesser AdamCEO and PresidentJul 11Sale322.989,6663,121,9560Jul 13 09:08 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryJul 03Sale340.18900306,16265,437Jul 06 08:22 PM
Sarna SurbhiDirectorJul 03Sale341.45279,2192,550Jul 06 08:23 PM
Elsesser AdamCEO and PresidentJun 12Option Exercise7.759,66674,9129,666Jun 14 08:43 PM
Elsesser AdamCEO and PresidentJun 12Sale324.499,6663,136,4810Jun 14 08:43 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryJun 01Sale309.30900278,36866,337Jun 05 07:28 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryMay 12Option Exercise22.0465214,37070,425May 16 07:32 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryMay 12Sale319.671,500479,50568,925May 16 07:32 PM
Elsesser AdamCEO and PresidentMay 11Option Exercise7.759,66674,9129,666May 15 07:31 PM
Elsesser AdamCEO and PresidentMay 11Sale318.529,6663,078,8620May 15 07:31 PM
Bose AraniDirectorMay 01Sale285.875,0001,429,328182,629May 03 07:50 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryApr 03Option Exercise22.0460013,22470,560Apr 05 07:32 PM
Bose AraniDirectorApr 03Sale275.595,0001,377,929431,342Apr 05 07:34 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryApr 03Sale278.14600166,88269,960Apr 05 07:32 PM
Sarna SurbhiDirectorApr 03Sale276.37287,7382,577Apr 05 07:31 PM
Grewal HarpreetDirectorMar 29Sale271.00875237,1259,660Mar 31 08:06 PM
Grewal HarpreetDirectorMar 15Sale254.98875223,10810,535Mar 17 08:06 PM